View Author
Theobald, M.
( M. Theobald)
patient myeloid leukemia leukemia group survival cytarabine treatment cycle g-csf study myeloid square meter chemotherapy factor induction high-dose remission university hospital psc -833 effect death -833 therapy center blood high-dose cytarabine granulocyte colony-stimulating factor table cytogenetic cr rate square meter analysis percent event-free survival event-free relapse trial result cancer outcome expression intermediate-dose ratio england journal copyright 2003 massachusetts treatment arm colony-stimulating resistance 2 treatment arms netherland value number erasmu high-dose group erasmus university hematology abnormality department interaction society intermediate-dose group consolidation therapy 60 years nejm.org massachusett disease-free survival copyright granulocyte phase multidrug induction chemotherapy disease-free granulocyte-macrophage colony-stimulating factor month medicine downloaded www.nejm.org cycles 1 consolidation
3 Most Recent Publications
|
Cytarabine dose for acute myeloid leukemia
(Article)
Löwenberg, B. Pabst, T. Greef, G.E. de Verdonck, L.F. Schaafsma, M.R. Gregor, M. Theobald, M. Schanz, U. Maertens, J. Ossenkoppele, G.J. Vellenga, E. Putten, W. van Schouten, H.C. Graux, C. Ferrant, A. Sonneveld, P. Biemond, B.J. Gratwohl, A. |
2011-03-17
|
|
The value of the MDR1 reversal agent PSC-833 in addition to daunorubicin and cytarabine in the treatment of elderly patients with previously untreated acute myeloid leukemia (AML), in relation to MDR1 status at diagnosis
(Article)
Holt, B. van der Verhoef, G.E.G. Knauf, W.U. Dugan, M. Shepherd, J. Piccaluga, P.P. Ossenkoppele, G.J. Vellenga, E. Ferrant, A. Fey, M.F. Crump, M. Theobald, M. Sonneveld, P. Selleslag, D. Löwenberg, B. Burnett, A.K. |
2005-01-01
|
|
Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia
(Article)
Löwenberg, B. Kovacsovics, T. Daenen, S.M.G.J. Ferrant, A. Gratwohl, A. Greef, G.E. de Putten, W.L.J. van Theobald, M. Gmur, J. Boogaerts, M. Verdonck, L.F. Sonneveld, P. Fey, M.F. Huijgens, P. |
2003-01-01
|
